Cancer Research Audrey Hepburn Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 57, 2870-2872, July 15, 1997]
© 1997 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, S.
Right arrow Articles by Takahashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, S.
Right arrow Articles by Takahashi, M.

Biological Properties of Ret with Cysteine Mutations Correlate with Multiple Endocrine Neoplasia Type 2A, Familial Medullary Thyroid Carcinoma, and Hirschsprung's Disease Phenotype1

Shinji Ito2, Toshihide Iwashita2, Naoya Asai, Hideki Murakami, Yosuke Iwata, Gen Sobue and Masahide Takahashi3

Departments of Pathology [S. I., T. I., N. A., H. M., Y. I., M. T.] and Neurology [S. I., G. S.], Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466, Japan

We investigated the transforming activity of the ret proto-oncogene with a mutation in cysteine 609, 611, 618, 620, 630, or 634 detected in patients with multiple endocrine neoplasia type 2A (MEN 2A), familial medullary thyroid carcinoma (FMTC), or Hirschsprung's disease. Of these cysteine mutations, codon 634 mutations are known to be correlated with the development of MEN 2A, whereas codon 609, 618, or 620 mutations were detected in two-thirds of FMTCs and in several cases of Hirschsprung's disease. Analysis of a total of 18 mutant genes revealed that codon 634 mutations have the highest transforming activity. The activity of ret with a codon 609, 611, 618, or 620 mutation and with a codon 630 mutation was approximately 3- to 5-fold and 2-fold lower than that of ret with a codon 634 mutation, respectively. In addition, different amino acid substitutions for the same cysteine displayed comparable transforming activity. The expression of the cell surface form of Ret with codon 609, 611, 618, or 620 mutation was very low compared with that of Ret with codon 634 mutation, indicating that the former four mutations might impair transport of Ret to the plasma membrane, as observed for several Hirschsprung mutations affecting the Ret extracellular domain. These results thus suggest that mutations in cysteine 609, 611, 618, or 620 may have the potential to develop Hirschsprung's disease in addition to MEN 2A and FMTC.

1 This work was supported in part by grants-in-aid for scientific research and for cancer research from the Ministry of Education, Science and Culture of Japan.

2 The first two authors contributed equally to this work.

3 To whom requests for reprints should be addressed. Phone: 52-744-2092; Fax: 52-744-2098.

Received 4/14/97. Accepted 6/10/97.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
S. A. Wells Jr. and M. Santoro
Targeting the RET Pathway in Thyroid Cancer
Clin. Cancer Res., December 1, 2009; 15(23): 7119 - 7123.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
A. Machens, S. Hauptmann, and H. Dralle
Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10
Endocr. Relat. Cancer, March 1, 2009; 16(1): 171 - 177.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G. H Sakorafas, H. Friess, and G. Peros
The genetic basis of hereditary medullary thyroid cancer: clinical implications for the surgeon, with a particular emphasis on the role of prophylactic thyroidectomy
Endocr. Relat. Cancer, December 1, 2008; 15(4): 871 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra
RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors
Endocr. Rev., August 1, 2006; 27(5): 535 - 560.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Carniti, S. Belluco, E. Riccardi, A. N. Cranston, P. Mondellini, B. A.J. Ponder, E. Scanziani, M. A. Pierotti, and I. Bongarzone
The RetC620R Mutation Affects Renal and Enteric Development in a Mouse Model of Hirschsprung's Disease
Am. J. Pathol., April 1, 2006; 168(4): 1262 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Machens, M. Brauckhoff, H.-J. Holzhausen, P. N. Thanh, H. Lehnert, and H. Dralle
Codon-Specific Development of Pheochromocytoma in Multiple Endocrine Neoplasia Type 2
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3999 - 4003.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Jijiwa, T. Fukuda, K. Kawai, A. Nakamura, K. Kurokawa, Y. Murakumo, M. Ichihara, and M. Takahashi
A Targeting Mutation of Tyrosine 1062 in Ret Causes a Marked Decrease of Enteric Neurons and Renal Hypoplasia
Mol. Cell. Biol., September 15, 2004; 24(18): 8026 - 8036.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. M. Melillo, A. M. Cirafici, V. De Falco, M. Bellantoni, G. Chiappetta, A. Fusco, F. Carlomagno, A. Picascia, D. Tramontano, G. Tallini, et al.
The Oncogenic Activity of RET Point Mutants for Follicular Thyroid Cells May Account for the Occurrence of Papillary Thyroid Carcinoma in Patients Affected by Familial Medullary Thyroid Carcinoma
Am. J. Pathol., August 1, 2004; 165(2): 511 - 521.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
G. Cuccuru, C. Lanzi, G. Cassinelli, G. Pratesi, M. Tortoreto, G. Petrangolini, E. Seregni, A. Martinetti, D. Laccabue, C. Zanchi, et al.
Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma
J Natl Cancer Inst, July 7, 2004; 96(13): 1006 - 1014.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
E. Arighi, A. Popsueva, D. Degl'Innocenti, M. G. Borrello, C. Carniti, N. M. Perala, M. A. Pierotti, and H. Sariola
Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease
Mol. Endocrinol., April 1, 2004; 18(4): 1004 - 1017.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Machens, P. Niccoli-Sire, J. Hoegel, K. Frank-Raue, T. J. van Vroonhoven, H.-D. Roeher, R. A. Wahl, P. Lamesch, F. Raue, B. Conte-Devolx, et al.
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
N. Engl. J. Med., October 16, 2003; 349(16): 1517 - 1525.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. Szinnai, C. Meier, P. Komminoth, and U. W. Zumsteg
Review of Multiple Endocrine Neoplasia Type 2A in Children: Therapeutic Results of Early Thyroidectomy and Prognostic Value of Codon Analysis
Pediatrics, February 1, 2003; 111(2): e132 - 139.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. Mograbi, R. Bocciardi, I. Bourget, T. Juhel, D. Farahi-Far, G. Romeo, I. Ceccherini, and B. Rossi
The Sensitivity of Activated Cys Ret Mutants to Glial Cell Line-Derived Neurotrophic Factor Is Mandatory To Rescue Neuroectodermic Cells from Apoptosis
Mol. Cell. Biol., October 15, 2001; 21(20): 6719 - 6730.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Machens, O. Gimm, R. Hinze, W. Höppner, B. O. Boehm, and H. Dralle
Genotype-Phenotype Correlations in Hereditary Medullary Thyroid Carcinoma: Oncological Features and Biochemical Properties
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1104 - 1109.
[Abstract] [Full Text]

Home page
 J. Med. Genet.Home page
J. R Hansford and L. M Mulligan
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis
J. Med. Genet., November 1, 2000; 37(11): 817 - 827.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
K. Kawai, T. Iwashita, H. Murakami, N. Hiraiwa, A. Yoshiki, M. Kusakabe, K. Ono, K.-i. Iida, A. Nakayama, and M. Takahashi
Tissue-specific Carcinogenesis in Transgenic Mice Expressing the RET Proto-Oncogene with a Multiple Endocrine Neoplasia Type 2A Mutation
Cancer Res., September 1, 2000; 60(18): 5254 - 5260.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
Y. Ishiguro, T. Iwashita, H. Murakami, N. Asai, K.-i. Iida, H. Goto, T. Hayakawa, and M. Takahashi
The Role of Amino Acids Surrounding Tyrosine 1062 in Ret in Specific Binding of the Shc Phosphotyrosine-Binding Domain
Endocrinology, September 1, 1999; 140(9): 3992 - 3998.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Pigny, C. Bauters, J.-L. Wemeau, M. Lecomte Houcke, M. Crepin, P. Caron, S. Giraud, A. Calender, M.-P. Buisine, J.-P. Kerckaert, et al.
A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1700 - 1704.
[Abstract] [Full Text]

Home page
 J. Med. Genet.Home page
S. M Myers, R. Salomon, A. Goessling, A. Pelet, C. Eng, A. von Deimling, S. Lyonnet, and L. M Mulligan
Investigation of germline GFRalpha -1 mutations in Hirschsprung disease
J. Med. Genet., March 1, 1999; 36(3): 217 - 220.
[Abstract] [Full Text]

Home page
 JCOHome page
C. Eng
RET Proto-Oncogene in the Development of Human Cancer
J. Clin. Oncol., January 1, 1999; 17(1): 380 - 380.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
R H Sijmons, R M W Hofstra, F A Wijburg, T P Links, R P Zwierstra, A Vermey, D C Aronson, G Tan-Sindhunata, G J Brouwers-Smalbraak, S M Maas, et al.
Oncological implications of RET gene mutations in Hirschsprung's disease
Gut, October 1, 1998; 43(4): 542 - 547.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Borrego, C. Eng, B. Sánchez, M.-E. Sáez, E. Navarro, and G. Antiñolo
Molecular Analysis of the ret and GDNF Genes in a Family with Multiple Endocrine Neoplasia Type 2A and Hirschsprung Disease
J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3361 - 3364.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
F. Carlomagno, R. M. Melillo, R. Visconti, G. Salvatore, G. De Vita, G. Lupoli, Y. Yu, S. Jing, G. Vecchio, A. Fusco, et al.
Glial Cell Line-Derived Neurotrophic Factor Differentially Stimulates Ret Mutants Associated with the Multiple Endocrine Neoplasia Type 2 Syndromes and Hirschsprung's Disease
Endocrinology, August 1, 1998; 139(8): 3613 - 3619.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.